Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Wilms Tumor × Bortezomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 89 Neoplasms, Plasma Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 6 Immunoglobulin Light-chain Amyloidosis 6 Recurrence 5 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Paraproteinemias 3 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Renal Insufficiency 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Amyloidosis 2 beta-Thalassemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Sarcoma, Myeloid 1 Plasmacytoma 1 Peripheral Nervous System Diseases 1 Neoplasm, Residual 1

Interventions

X-Rays 7 Phantoms, Imaging 7 Specimen Handling 6 Magnetic Resonance Spectroscopy 6 Nuclear Medicine Department, Hospital 5 Biopsy 5 fludarabine 3 Vincristine 3 Cyclophosphamide 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 fludarabine phosphate 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Radiotherapy 2 Radiation 2 Irinotecan 2 Etoposide 2 Doxorubicin 2 tazemetostat 1 talazoparib 1 selinexor 1 sargramostim 1 pembrolizumab 1 palbociclib 1 omburtamab I-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡